» Articles » PMID: 23526719

Transfection Efficiency of Normal and Cancer Cell Lines and Monitoring of Promoter Activity by Single-cell Bioluminescence Imaging

Overview
Journal Luminescence
Specialties Biochemistry
Biophysics
Date 2013 Mar 26
PMID 23526719
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

The bioluminescence system (luciferase reporter assay system) is widely used to study gene expression, signal transduction and other cellular activities. Although transfection of reporter plasmid DNA to mammalian cell lines is an indispensable experimental step, the transfection efficiency of DNA varies among cell lines, and several cell lines are not suitable for this type of assay because of the low transfection efficiency. In this study, we confirm the transfection efficiency of reporter DNA to several cancer and normal cell lines after transient transfection by single-cell imaging. Luminescence images could be obtained from living single cells after transient transfection, and the calculated transfection efficiency of this method was similar to that of the conventional reporter assay using a luminometer. We attempted to measure the activity of the Bip promoter under endoplasmic reticulum stress conditions using both high and low transfection efficiency cells for plasmid DNA at the single-cell level, and observed activation of this promoter even in cells with the lowest transfection efficiency. These results show that bioluminescence imaging of single cells is a powerful tool for the analysis of gene expression based on a reporter assay using limited samples such as clinical specimens or cells from primary culture, and could provide additional information compared with the conventional assay.

Citing Articles

Evaluation of DNA minicircles for delivery of adenine and cytosine base editors using activatable gene on "GO" reporter imaging systems.

Evans M, Liu S, Krautner J, Seguin C, Leung R, Ronald J Mol Ther Nucleic Acids. 2024; 35(3):102248.

PMID: 39040503 PMC: 11260848. DOI: 10.1016/j.omtn.2024.102248.


DNA Double Strand Break and Response Fluorescent Assays: Choices and Interpretation.

Atkinson J, Bezak E, Le H, Kempson I Int J Mol Sci. 2024; 25(4).

PMID: 38396904 PMC: 10889524. DOI: 10.3390/ijms25042227.


Transfection of Sponge Cells and Intracellular Localization of Cancer-Related MYC, RRAS2, and DRG1 Proteins.

Dominko K, Talajic A, Radic M, Vidacek N, Vlahovicek K, Herak Bosnar M Mar Drugs. 2023; 21(2).

PMID: 36827160 PMC: 9964533. DOI: 10.3390/md21020119.


Combination of Nanovectorized siRNA Directed against Survivin with Doxorubicin for Efficient Anti-Cancer Activity in HER2+ Breast Cancer Cells.

Eljack S, Allard-Vannier E, Misericordia Y, Herve-Aubert K, Aubrey N, Chourpa I Pharmaceutics. 2022; 14(11).

PMID: 36432729 PMC: 9696063. DOI: 10.3390/pharmaceutics14112537.


Development of appropriate fatty acid formulations to raise the contractility of constructed myocardial tissues.

Yoshida A, Sekine W, Homma J, Sekine H, Itoyama Y, Sasaki D Regen Ther. 2022; 21:413-423.

PMID: 36248630 PMC: 9525806. DOI: 10.1016/j.reth.2022.09.006.